Blockchain Registration Transaction Record

Lantern Pharma to Present at ThinkEquity Conference on Oct. 15, 2026

Lantern Pharma (NASDAQ: LTRN) to present at ThinkEquity Conference on Oct. 15, 2026, at 3:30 p.m. ET. Live webcast and investor meetings available.

This news matters because it provides investors with a direct opportunity to hear from Lantern Pharma's management about the company's progress and vision. As an AI-driven oncology company, Lantern Pharma is at the intersection of two rapidly growing fields: artificial intelligence and precision medicine. The RADR platform's potential to streamline drug development and improve patient outcomes could significantly disrupt the traditional oncology landscape. Investors attending the presentation or tuning into the webcast will gain insights into Lantern's pipeline, including LP-184, LP-300, and LP-284, as well as its subsidiaries, Starlight Therapeutics and Open-Medicine AI. Such events can influence market perception and investment decisions, especially for a clinical-stage company where milestones and data readouts are critical. Moreover, the involvement of InvestorWire and IBN underscores the importance of effective communication in reaching a broad investor base. As AI continues to revolutionize healthcare, Lantern Pharma's advancements could lead to more personalized and effective cancer treatments, making this a noteworthy event for both the medical and investment communities.